B+
Bull case
25%
Probability
Target price
$1,020.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
MCK
McKessonBNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
55%
Probability
Target price
$940.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$790.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-08
Recent news sentiment (30D)
+0.7
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+70.4
Score
AI commentary
The company-source tone is positive following the August 5 results and guidance raise. The RankAlpha anchor was $871.38 on August 6, but the packet lacks a pre-release comparator and reliable post-print analyst revisions, so the market reaction cannot be cleanly attributed and confidence remains tentative.
RankAlpha Sentiment Codex - 2026-08-08
Open post-earnings memoEvidence flagged
high-coverage report lacks a dated company-specific catalyst beyond generic cadence; later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence
Impact
tentative
Confidence
-
AI events
2026-08-05eventSpecialty and oncology operating momentumHigh impact
The August 5 release identified increased prescription volumes, specialty-product distribution, and continued Oncology & Multispecialty growth as operating drivers. [#SEC-8K-2026-08-05]
2026-08-05catalystQ1 FY27 results and guidance raiseMedium impact
On August 5, McKesson reported Q1 revenue of $105.4 billion, adjusted EPS of $9.93, and raised FY27 adjusted EPS guidance to $44.20-$45.00 from $43.80-$44.60. [#SEC-8K-2026-08-05]
2027-08-08catalystPlanned Medical-Surgical Solutions separationMedium impact
McKesson disclosed continued preparation for the planned Medical-Surgical Solutions separation and introduced the future standalone business name Wellverse; execution timing was not specified. [#SEC-8K-2026-08-05]
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-08 • Updated nightlySource: Internal modelMethodology